BioSpace News Archive

Galectin Therapeutics Granted Patents in China and Japan that Support NASH and Cancer Immunotherapy Clinical Development Programs

The broad protection of these patents opens doors to partnerships in the world’s second- and third-largest pharmaceutical markets.

January 25, 2018
·
6 min read
Business

Meridian Bioscience Reports First Quarter 2018 Operating Results, Declares Regular First Quarter Cash Dividend, and Reaffirms Fiscal 2018 Guidance

The company reported first quarter net revenues of $52.3 million, an increase of 12% from the same period of the prior fiscal year.

January 25, 2018
·
17 min read
Pharm Country

Athenex Announces Pricing of Offering of Common Stock

In addition, Athenex has granted the underwriters a 30-day option to purchase up to an additional 645,000 shares of common stock at the same price.

January 25, 2018
·
3 min read
Drug Development

Ezutromid Significantly Reduced Muscle Damage in DMD Patients in 24-Week Interim Data From Summit’s PhaseOut DMD Clinical Trial

PhaseOut DMD is evaluating the utrophin modulator ezutromid in patients with Duchenne muscular dystrophy (‘DMD’). The focus of the planned interim analysis was on biopsy measures that show:

January 25, 2018
·
11 min read
Deals

Bay Area’s Menlo Therapeutics Prices IPO at $17 Per Share

The offering is expected to close on January 29, 2018, subject to customary closing conditions.

January 25, 2018
·
2 min read
Business

NeuroMetrix Reports Q4 and Full Year 2017 Financial Results

The Company develops and markets novel therapies, based on neurostimulation and digital medicine, for chronic health conditions.

January 25, 2018
·
6 min read
Drug Development

GW Pharmaceuticals and Its U.S. Subsidiary Greenwich Biosciences Announce Publication of Landmark Epidiolex (Cannabidiol) Study in The Lancet

Treatment with Epidiolex was generally well tolerated, with a safety profile consistent with prior reported experience.

January 25, 2018
·
12 min read
Biotech Beach

REVA Announces First Implant of the Fantom Bioresorbable Scaffold in Italy

The procedure was conducted by Dr. Bernardo Cortese at the Fatebenefratelli Hospital in Milan.

January 25, 2018
·
4 min read
Drug Development

Adocia Announces Positive Topline Data From a Dose-Proportionality Study of BioChaperone Combo in People With Type 2 Diabetes

Adocia announced today positive topline results from a Phase 1b clinical trial.

January 25, 2018
·
5 min read
Biotech Bay

Iovance Biotherapeutics Announces Public Offering of Common Stock - Jan. 25, 2018

Iovance intends to use the proceeds from this offering to fund its ongoing clinical trials for its current product candidates, including its ongoing Phase 2 clinical trials of LN-144.

January 25, 2018
·
4 min read